TAMIS-IPAA vs. Lap-IPAA for Ulcerative Colitiis

Sponsor
Jinling Hospital, China (Other)
Overall Status
Unknown status
CT.gov ID
NCT03536988
Collaborator
(none)
84
1
2
31.7
2.7

Study Details

Study Description

Brief Summary

The objective of this RCT is to compare the postoperative outcome of transanal versus transabdominal minimally invasive proctectomy with ileal pouch-annal anastomosis in patients with ulcerative colitis.

Condition or Disease Intervention/Treatment Phase
  • Procedure: TAMIS-IPAA
  • Procedure: Lap-IPAA
N/A

Detailed Description

Theoritically, the advantge of TAMIS surgery over traditional trans-abdominal IPAA surgery incudes shorter operation time due to simulatous surgery transanlly and transabdominally, reduced operative difficulty in narrow male pelvis, less retained rectal cuff and less "dog-ear" formation. However, its adgange has not been proven in prospecitve randomized trials. The aim of current study is to compare the short and long-term postoperative outcome of transanal versus transabdominal minimally invasive proctectomy with ileal pouch-annal anastomosis in patients with ulcerative colitis.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
84 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Transanal Versus Transabdominal Minimally Invasive Proctectomy With Ileal Pouch-annal Anastomosis On Postoperative Outcomes in Ulcerative Colitis: a Randomized Controlled Trial
Actual Study Start Date :
Apr 12, 2018
Anticipated Primary Completion Date :
Sep 1, 2020
Anticipated Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: TAMIS-IPAA

In TAMIS-IPAA group, transanal minimally invasive surgery of proctectomy with IPAA will be performed.

Procedure: TAMIS-IPAA
In TAMIS-IPAA group, transanal minimally invasive surgery of IPAA will be performed.

Active Comparator: Lap-IPAA

In Lap-IPAA group, transabdominal minimally invasive surgery of proctectomy with IPAA will be performed.

Procedure: Lap-IPAA
In Lap-IPAA group, transabdominal minimally invasive surgery of IPAA will be performed.

Outcome Measures

Primary Outcome Measures

  1. Postoperative Complications [Day 30]

    Postoperative complcations were documented using comprehensive complication index(CCI)

Secondary Outcome Measures

  1. Duration of operation [24 Hr]

    The duration of operation will be documented in minutes, from skin incision to dress coverage

  2. The incidence of pouch extension [24 Hr]

    the need to extend the length of pouch during operation

  3. Intraoperative complications [24 Hr]

    Including anastomotic burst, iatrogenic injury

  4. Estimated blood loss [24 Hr]

    in mLs during surgery

  5. Postoperative anastmotic leakage [Day 90]

    Anastomotic leakage was defined as any defect at the anastomotic site confirmed by imaging or during surgical re-intervention, and was categorised according to the impact on clinical management [A, B, C]. Grade A leaks had minimal to no clinical impact on the patient's postoperative course, requiring antibiotics at the most. Grade B leaks required active intervention such as radiological placement of a pelvic drain or transanal lavage. Grade C leaks required re-operation, mostly because the patient was not defunctioned.

  6. Time to GI-2 recovery [Day 90]

    Time to GI-2 recovery, a composite end point of the later of upper (first toleration of solid food) and lower (first bowel movement) GI function.

  7. Postoperative length of hospital stay [Day 90]

    in days

  8. Overall cost of treatment [up to 1 year]

    In Chinese Yuan (CNY)

  9. Remaining length of anal mucosa. [24 Hr]

    The mean lenght of four quadrant during pouchoscopy 2 months after opertion, the length was calculated from the dental line to the anastomotic site.

  10. The incidence of cuffitis and pouchitis [up to 1 year]

    Pouchitis is defined as inflammatory condition of the ileal pouch reservoir, while cuffitis is defined as the inflammatory condition of the remnant rectal cuff.

  11. Postoperative quality of life [up to 1 year]

    Postoperative quality of life(QoL) is determined using Inflammatory Bowel Disease-Questionaire(IBD-Q)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Clincially and pathologically proven ulcerative colitis

  • Aged 18-75 years

  • Patients who will undergo proctectomy and IPAA surgery, incuding the first stage of two-stage surgery, or the second stage of three-stage or modified two-stage surgery

  • Elective surgery

  • Informed constent obtained.

Exclusion Criteria:
  • A contraindication for minimally invasive surgery or TAMIS surgery

  • Ileus or peritonitis

  • Previous surgery in rectum

  • Pregnancy

  • Carcinogenesis of rectum, dysplasia or stricture of ATZ, or planned mucosectomy

  • Patients with planned permnant ileostomy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Generay Surgery, Jinling hosptal, Medical School of Nanjing University Nanjing Jiangsu China 210000

Sponsors and Collaborators

  • Jinling Hospital, China

Investigators

  • Principal Investigator: Jianfeng Gong, Jinling Hospital, China

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jianfeng Gong, associate professor, Jinling Hospital, China
ClinicalTrials.gov Identifier:
NCT03536988
Other Study ID Numbers:
  • JinlingH TAMIS
First Posted:
May 25, 2018
Last Update Posted:
May 25, 2018
Last Verified:
Jan 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jianfeng Gong, associate professor, Jinling Hospital, China
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 25, 2018